In vitro characterization of a slow release system of polylactic acid and rhBMP2

Journal of Biomedical Materials Research - Part A

Volumn 83, Issue 2, 2007, Pages 455-462

  Schliephake, H ^a   Weich, H A ^b   Schulz, J ^a   Gruber, R ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Bone morphogenic proteins; Controlled release; Growth factors; Polymers

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENIC PROTEINS; CONTROLLED RELEASE; GRANULAR POWDER; GROWTH FACTORS; POLYLACTIC ACID;

CELL CULTURE; IMPLANTS (SURGICAL); POLYMERS; PROTEINS; VISCOSITY;

ORGANIC ACIDS;

ALKALINE PHOSPHATASE; POLYLACTIC ACID; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RESOMER R 208; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DEGRADATION; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEZE DRYING; IN VITRO STUDY; NONHUMAN; POWDER; SCANNING ELECTRON MICROSCOPY; VISCOSITY;

ABSORBABLE IMPLANTS; ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL LINE; DELAYED-ACTION PREPARATIONS; ENZYME INDUCTION; GASES; HUMANS; HYDROGEN-ION CONCENTRATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LACTIC ACID; MICE; MICROSCOPY, ELECTRON, SCANNING; POLYMERS; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 35048862463     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31227     Document Type: Article

References (34)

1. Wikesjö UME, Sorensen RG, Wozney JM. Augmentation of alveolar bone and dental implant osseointegration: Clinical implications of studies with rhBMP2. J Bone Joint Surg 2001;83-A(Suppl 1):S1-136-S1-146
2. Schliephake H. Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 2002;31:469-484.
3. Valentin-Opran A, Wozney J, Csimma C, Lilly LC, Riedel GE. Clinical evaluation of recombinant human bone morphogenetic protein 2. Clin Orthop Rel Res 2002;395:110-120.
4. Ripamonti U. Soluble osteogenic molecular signals and the induction of bone formation. Biomaterials 2006;27:807-822.
5. Boyne PJ, Lilly LC, Marx RE, Moy PK, Nevins M, Spagnoli DB, Triplett RG. De novo bone induction by recombinant human bone morphogenetic protein-2(rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg 2005;63:1693-1707.
6. Jung RE, Glauser R, Schärer P, Hämmerle CH, Sialer HF, Weber FE. Effect of rhBMP-2 on guided bone regeneration in humans. Clin Oral Impl Res 2003;14:556-568.
7. Van den Bergh JPA, ten Bruggenkate CM, Groeneveld HHJ, Burger EH, Tuinzing DB. Recombinant human bone morphogenetic protein-7 in maxillary sinus floor elevation surgery in 3 patients compared to autogenous bone grafts. J Clin Periodontal 2000;27:627-636.
8. Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC, Alder M, Numikoski P. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 1997;17:11-25.
9. Cochran L, Jones AA, Lilly LC, Fiorellini JP, Howard H. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontal 2000;71:1241-1257
10. Uludag H, D'Augusta D, Golden J, Li J, Timony G, Riedel R, Wozney JM. Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: a correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. J Biomed Mater Res 2000;50:227-238.
11. Kanematsu A, Yamamoto S, Ozeki M, Nopguchi T, Kanatani I, Ogawa O, Tabata Y. Collagenous marices as release carriers of exogenous growth factors. Biomaterials 2004;25:4513-4520.
12. Yamamoto M, Takahashi Y, Tabata Y. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 2003;24:4375-4383.
13. Saito N, Okada T, Horiuchi H, Ota H, Takahashi J, Murakami N, Nawata M, Kojima S, Nozaki K, Takaoka K. Local bone formation by injection of recombinant human bone morphogenetic protein-2 contained in polymer matrices. Bone 2003;32:381-386.
14. Cleland JL, Duenas ET, Park A, Daugherty A, Kahn J, Kowalski J, Cuthbertson. Deveopment of poly-(D,L-lactide-coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J Controlled Release 2001;72:13-24.
15. King T, Patrik CW. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poyl(DL-lactic-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique. J Biomed Mater Res 2000;51:383-390.
16. Hu Y, Hollinger JO, Marra KG. Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds. J Drug Targeting 2001;9:431-438.
17. Tschakaloff A, Von Oepen R, Seibt S, Vieting M. Das Begasungsverfahren zur Beladung resorbierbarer Polymere mit thermolabilen Substanzen. Dtsch Z Mund Kiefer GesichtsChir 1996;20:47-50.
18. Mooney DJ, Baldwin DF, Suh NP, Vacanti JP, Langer R. Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials 1996;17:1417-1422.
19. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nature Biotechnol 2001;19:1029-1034.
20. 2. J Controlled Release 2000;15:177-185.
21. Howdle SM, Watson MS, Whitaker MJ, Propov VK, Davies MC, Mandel FS, Wang JD, Sjakesheff KM. Supercritical fluid mixing: Preparation of thermally sensitive polymer composites containing bioactive materials. Chem Commun 2001;109-110.
22. Vallejo LF, Brokelmann M, Marten S, Trappe S, Cabrera-Crespo J, Hofmann A, Gross G, Weich HA, Rinas U. Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli. J Biotechnol 2002;94:185-194.
23. Weihe S, Wehmöller M, Schliephake H, Hassfeld S, Tschakaloff A, Radczkowsky J, Eufinger H. Synthesis of CAD/CAM, robotics and biomaterial implant fabrication: single step reconstruction in computer-aided frontotemporal bone resection. Int J Oral Maxillofac Surg 2000;29:384-388.
24. Schiller C, Rasche C, Wehmöller M, Beckmann F, Eufinger H, Epple M, Weihe S. Geometrically structured implants for cranial reconstruction made of biodegradable polyesters and calcium phosphate/calcium carbonate. Biomaterials 2004;25:1239-1247.
25. Tschakaloff A, Schliephake H, Dard M. Pilot study of controlled liberation of growth factor from polylactide implants. Mund Kiefer Gesichtschir 2000;4:S474-S478.
26. Harris LD, Kim BO, Mooney DJ. Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res 1998;42:396-402.
27. Shea LD, Smiley E, Bonadio J, Mooney DJ. DNA delivery from polymer matrices for tissue engineering. Nature Biotechnol 1999;17:551-554.
28. Yang X, Whitaker MJ, Sebald W, Clarke N, Howdle SM, Shakesheff KM, Oreffo ROC. Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds. Tissue Eng 2004;10:1037-1045.
29. Schliephake H, Dard M, Planck H, Hierlemann H, Jakob A. Guided bone regeneration around endosseous implants using a resorbable membrane vs. a PTFE membrane. Clin Oral Implants Res 2000;11:230-241.
30. Lorenzoni M, Pertl C, Keil C, Wegscheider WA. Treatment of peri-implant defects with guided-bone regeneration: a comparative clinical study with various membranes and bone grafts. Int J Oral Maxillofac Implants 1998;13:639-646.
31. Schliephake H, Klosa D, Rahlff M. Determination of the 3D morphology of degradable biopolymer implants undergoing in vivo resorption. J Biomed Mater Res 1993;27:991-998.
32. Vert M, Suming LI, Gareau H. New insights on the degradation of bioresorbable polymeric devices based on lactic and glycolic acids. Clin Mater 192;10:3-8.
33. Bergsma JE, de Bruijn WC, Rozema FR, Bos RR, Boering G. Late degradation tissue response to poly(L-lactide) bone plates and screws. Biomaterials 1995;16:25-31.
34. Thombre AG, Himmelstein KJ. A simultaneous transport-reaction model for controlled drug delivery from catalyzed bioerodible polymer matrices. AIChe J 1985;31:759-766.